$0.7810
-0.083-9.61%
Dern. MÀJ: Oct 23, 6:54 PM
Dermata Therapeutics (DRMA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.55 | $-0.53 | $-1.54 | $-1.59 |
| Actual | $-0.74 | $-0.48 | $-1.52 | $-1.65 |
| Surprise | -34.5% | +9.43% | +1.30% | -3.77% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | — | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.55 | $-0.46 |
| Revenue | ||
| Consensus | $25000 | $75000 |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.74 | $-0.55 | -34.5 % |
| Q1 | May 13, 2026 | $-0.48 | $-0.53 | 9.43 % |
| Q4 | Mar 26, 2026 | $-1.52 | $-1.54 | 1.30 % |
| Q3 | Nov 14, 2025 | $-1.65 | $-1.59 | -3.77 % |